Literature DB >> 1108322

Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of "Hodgkin's-like" reticulum cell sarcoma in SJL mice.

R L Truitt, M Pollard.   

Abstract

"Hodgkin's-like reticulum cell sarcoma develops spontaneously in most SJL mice. Germ-free and conventional SJL mice bearing advanced reticulum cell sarcoma were treated with X-irradiation and transplantation of bone marrow from SJL or C3H/He donors. The 120-day survival rate of germ-free mice receiving allogeneic bone marrow (70%) exceeded that of all control groups; more importantly, germ-free mice that survived more than 4 months after treatment with allogeneic cells had no evidence of neoplastic lesions when killed. The germ-free environment effectively prevented graft-versus-host disease that was lethal to conventional mice. The results of these experiments offer additional evidence that bone marrow transplantation can be used as a therapeutic tool for spontaneous murine neoplasms.

Entities:  

Mesh:

Year:  1976        PMID: 1108322     DOI: 10.1097/00007890-197601000-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

Authors:  P K Pattengale; C R Taylor
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

2.  Hodgkin's disease. SJL/J murine lymphoma.

Authors:  R K Kumar
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

3.  Effect of cyclophosphamide on development of reticulum cell sarcoma in SJL/J mice.

Authors:  C G Crispens
Journal:  Experientia       Date:  1982-05-15

Review 4.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Authors:  Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-19       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.